DW Healthcare Partners Invests in Vets Plus and Noble Pharma
January 10, 2022
DW Healthcare Partners completed a growth capital investment in Vets Plus, Inc. and Noble Pharma, LLC, backing the animal-health manufacturer to scale operations and expand pharmaceutical capabilities. As part of the transaction, Dave Nelson becomes President and CEO of Vets Plus while founder Raj Lall transitions from day-to-day management and remains on the board.
- Buyers
- DW Healthcare Partners
- Targets
- Vets Plus, Inc., Noble Pharma, LLC
- Industry
- Veterinary
- Location
- Wisconsin, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Parnell Acquires Noble Pharma LLC
April 11, 2026
Healthcare Services
Parnell announced it has acquired Noble Pharma LLC, a U.S.-based pharmaceutical manufacturer, under a Securities Purchase Agreement dated November 26, 2025. The deal adds an FDA- and DEA-accredited manufacturing facility in Menomonie, Wisconsin, to strengthen Parnell’s U.S. manufacturing capabilities and supply continuity.
-
Veterinary Pharmaceutical Solutions Acquires Diamond Animal Health
January 18, 2024
Veterinary
Veterinary Pharmaceutical Solutions (VPS), a Granite Creek Capital Partners portfolio company, acquired Diamond Animal Health from Mars Corporation. Granite Creek supported the deal with a follow-on investment from its FlexCap II fund, creating an integrated animal health platform combining VPS's compounding capabilities with Diamond's contract manufacturing and vaccine production.
-
Whistler Capital Partners Makes Strategic Growth Investment in Heart + Paw
January 3, 2024
Healthcare Services
Whistler Capital Partners, a Nashville-based healthcare-focused private equity firm, has made a significant strategic growth investment in Heart + Paw, a multi-service veterinary and pet care platform. The capital will support Heart + Paw’s de novo expansion, technology and operations investments, and its veterinarian joint-venture model; financial terms were not disclosed.
-
Dechra Pharmaceuticals Acquires Med-Pharmex from DW Healthcare Partners
August 30, 2022
Veterinary
Dechra Pharmaceuticals PLC has completed the acquisition of Med-Pharmex Holdings, Inc. from DW Healthcare Partners. The deal brings a US-based, fully integrated veterinary pharmaceutical manufacturer (Med-Pharmex) into Dechra's global animal-health platform to strengthen its manufacturing capabilities and North American footprint.
-
DW Healthcare Partners Invests in Bio Agri Mix
July 27, 2021
Veterinary
DW Healthcare Partners completed an investment in Bio Agri Mix LP, Canada’s largest manufacturer and distributor of medicated feed additives and water-soluble animal medications. As part of the transaction DWHP partners join Bio Agri Mix’s board and will support expansion of the company’s product portfolio and growth across the North American livestock market.
-
DW Healthcare Partners Invests in Parnell Pharmaceuticals
February 1, 2021
Veterinary
DW Healthcare Partners completed an investment in Parnell Pharmaceuticals Holdings Ltd, a fully integrated animal-health pharmaceutical developer and sterile-injectable manufacturer, and took seats on the company's board. DWHP said the capital and board expansion will support Parnell's growth in the U.S. and expansion of its product portfolio and manufacturing capabilities in animal health.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.